Diuretic and antidiuretic effects of furosemide before and during the early period of pitressin therapy in diabetes insipidus.
D003919:Diabetes Insipidus / Q000188:drug therapy / Q000503:physiopathology*; D004231:Diuresis / Q000187:drug effects*; D005260:Female; D005665:Furosemide / Q000494:pharmacology*; D005919:Glomerular Filtration Rate; D006801:Humans; D006982:Hypertonic Solutions; D007668:Kidney / Q000098:blood supply; D007671:Kidney Concentrating Ability; D008875:Middle Aged; D009994:Osmolar Concentration; D011188:Potassium / Q000652:urine; D012039:Regional Blood Flow; D012964:Sodium / Q000652:urine; D012965:Sodium Chloride / Q000494:pharmacology; D014556:Urine; D014667:Vasopressins / Q000627:therapeutic use*; D014867:Water / Q000378:metabolism
D006982:Hypertonic Solutions; D014867:Water; D014667:Vasopressins; D012965:Sodium Chloride; D005665:Furosemide; D012964:Sodium; D011188:Potassium